Oxford University Press (OUP), The Journal of Infectious Diseases, 7(204), p. 987-995
Full text: Download
Background. Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and viral death in infants. Despite decades of research with traditional or subunit vaccine approaches, there are no approved RSV vaccines. New approaches are therefore urgently needed to develop effective RSV vaccines.